Down-regulation of miR-145 expression was not associated with PR status in breast cancer, but was lowly expressed in breast cancer patients with ER-positive, HER-2-positive and lymph node metastasis, and was closely related to tumor size. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.